Accessibility Menu
Novartis Ag logo

Novartis Ag

(XSWX) NOVN

Current PriceCHF 127.92
Market CapCHF 234.16B
Since IPO (1996)+868%
5 Year+51%
1 Year+32%
1 Month+13%

Novartis Ag Financials at a Glance

Market Cap

CHF 234.16B

Revenue (TTM)

$24.71M

Net Income (TTM)

$999.00K

EPS (TTM)

CHF 5.61

P/E Ratio

22.64

Dividend

CHF 3.70

Beta (Volatility)

0.03 (Low)

Price

CHF 127.92

Volume

1,777,730

Open

CHF 127.84

Previous Close

CHF 128.02

Daily Range

CHF 127.28 - CHF 128.22

52-Week Range

CHF 91.20 - CHF 131.00

Estimated Earnings Date

Aug 9, 2023

NOVN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novartis Ag

Industry

Pharmaceuticals

Employees

75,267

CEO

Vasant Narasimhan, MD

Headquarters

Durham, CA 27703, US

NOVN Financials

Key Financial Metrics (TTM)

Gross Margin

68.74%

Operating Margin

-149.90%

Net Income Margin

-82.85%

Return on Equity

-170.66%

Return on Capital

-414.65%

Return on Assets

-21.66%

Earnings Yield

4.42%

Dividend Yield

2.89%

Payout Ratio

0.00%

Stock Overview

Market Cap

CHF 234.16B

Shares Outstanding

1.83B

Volume

1.78M

Avg. Volume

2.52M

Financials (TTM)

Gross Profit

$16.26M

Operating Income

-$35.63M

EBITDA

-$28.18M

Operating Cash Flow

-$35.90M

Capital Expenditure

-$3.37M

Free Cash Flow

-$39.27M

Cash & ST Invst.

$12.54M

Total Debt

$3.85M

Novartis Ag Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2023YOY CHG

Revenue

$3.00M

+58.4%

Gross Profit

$1.71M

+1.5%

Gross Margin

57.11%

N/A

Market Cap

CHF 234.16B

N/A

Market Cap/Employee

CHF 2.60B

N/A

Employees

90

N/A

Net Income

-$14.12M

-4.3%

EBITDA

-$12.85M

+1.4%

Quarterly Fundamentals

Name
Q1 2023YOY CHG

Total Cash

$12.54M

-64.7%

Total Debt

$3.85M

-81.3%

Accounts Receivable

$13.84M

-13.6%

Inventory

$1.12M

-24.5%

Long Term Debt

$3.39M

-83.4%

Short Term Debt

$465.00K

+103.9%

Return on Assets

-21.66%

N/A

Return on Invested Capital

-80.56%

N/A

Free Cash Flow

-$4.27M

-2537.7%

Operating Cash Flow

-$4.25M

-654.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PTNPalatin Technologies, Inc.
$11.59+12.20%
QTTBQ32 Bio Inc.
$13.09+3.89%
ARAVAravive, Inc.
$0.04-13.39%
BPTSBiophytis S.A.
$8.22-13.47%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.92-0.01%
TAT&T
$20.58+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%
CLROClearOne
$6.48+1.01%

Questions About NOVN

What is the current price of Novartis Ag?

Novartis Ag is trading at CHF 127.92 per share.

What is the 52-week range for Novartis Ag?

Over the past 52 weeks, Novartis Ag has traded between CHF 91.20 and CHF 131.00.

How much debt does Novartis Ag have?

As of the most recent reporting period, Novartis Ag reported total debt of $37.77B.

How much cash does Novartis Ag have on hand?

Novartis Ag reported $5.53B in cash and cash equivalents in its most recent financial results.

What is Novartis Ag’s dividend yield?

Novartis Ag currently has a dividend yield of 2.89%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.